Missing data

Missing data

Author: The BMJ August 27, 2013 Duration: 23:25

The problem of missing data is well known, especially in cases where drug companies conceal evidence. However pharmaceutical industry misconduct is not the only cause, and a cluster of papers in this week's BMJ show how aspects of the culture of medical science contribute to the problem.

Elizabeth Loder, BMJ's clinical editor, talks to Harlan Krumholz (Harold H Hines Jr professor of medicine at Yale University) and Joseph Ross (assistant professor of medicine, also at Yale) about missing data from US publicly funded trials. Lisa Bero (professor at the Department of Clinical Pharmacy, University of California) describes how adding missing data to meta-analyses of drug trials can change the results, and Richard Riley (senior lecturer in medical statistics at Birmingham University) explains why individual participant meta-analyses aren't as balanced as we may think.


Produced by The BMJ, this weekly audio series delves into the pivotal research and urgent clinical debates shaping modern medicine. Each episode moves beyond the published page, bringing together the authors, critics, and practitioners directly involved to dissect a new study or a pressing health question. The conversation is rigorous and nuanced, designed for those who appreciate the complexity behind headlines. You’ll hear unscripted discussion about methodology, implications for practice, and the occasional healthy disagreement that drives science forward. This isn't just a summary of the latest findings; it's a critical appraisal in real time, offering listeners a front-row seat to the evolving discourse that defines evidence-based care. The Medicine and Science from The BMJ podcast serves as an essential audio companion for clinicians, academics, and anyone keen to understand the ‘why’ and ‘how’ behind medical news. It transforms the latest evidence from the journal into an accessible, thought-provoking dialogue, ensuring that busy professionals can stay deeply informed. Tune in for a direct, intelligent, and often surprising take on the science that matters most.
Author: Language: English Episodes: 1000

Medicine and Science from The BMJ
Podcast Episodes
Born equal - the launch of The BMJ special issue on race in medicine [not-audio_url] [/not-audio_url]

Duration: 28:27
Last week the BMJ published it’s first special edition into Racism in Medicine. The issues tacked ranged from differential attainment in medical school, to the physiological effects that experiencing everyday discriminat…
Talk Evidence - Building an evidence base for covid-19 [not-audio_url] [/not-audio_url]

Duration: 44:56
We're taking a break from the usual Talk Evidence to focus on the new corona virus that has emerged in China. With a brand new disease, we have to build our evidence base from scratch - basic virology, epidemiology, path…
Big Tan - Is  the sunbed industry targeting research? [not-audio_url] [/not-audio_url]

Duration: 29:20
In 2012, Eleni Linos, professor of dermatology at Stanford university, published a systematic review and meta-analysis of the link between non-melanoma cancer and sun-beds. That bit of pretty standard research, and a par…
Writing a good outpatient letter means addressing it to the patient [not-audio_url] [/not-audio_url]

Duration: 24:46
In many countries (including the UK and Australia) it is still common practice for hospital doctors to write letters to patients’ general practitioners (GPs) following outpatient consultations, and for patients to receiv…
QI and improvement are not synonyms [not-audio_url] [/not-audio_url]

Duration: 45:10
In October 2019, Mary Dixon-Woods, director of the THIS Institute, dedicated to healthcare improvement. In that she explained how she believed healthcare improvement could be improved. The essay took the position that "Q…
Prevalence and treatment of  precocious puberty [not-audio_url] [/not-audio_url]

Duration: 34:09
Precocious puberty, that is puberty that starts before age 8 in girls and 9 in boys seems to be on the rise, but whether that’s because of an increase in incidence, or greater attention is unknown - what we do know that…
Talk Evidence - Sepsis, talc and blindsided by blinding [not-audio_url] [/not-audio_url]

Duration: 41:07
Welcome to the festive talk evidence, giving you a little EBM to take you into the new year. As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director…
Surviving childhood cancer treatment [not-audio_url] [/not-audio_url]

Duration: 24:42
In a British cohort, 30% of patients who had survived childhood cancer had died within 45 years of diagnosis; only 6% were expected to have died. 51% had developed a new primary cancer, but a 26% died of cardiovascular d…
Is it possible to have fair pricing for medicines [not-audio_url] [/not-audio_url]

Duration: 26:17
Is it possible to have a fair price for medicines? Yes, according to a new collection just published on bmj.com. The authors set out to evaluate how we could improve the functioning of the market for medicines, to honest…